ZA959762B - Proteins having fibrinolyic and coagulation-inhibiting properties - Google Patents

Proteins having fibrinolyic and coagulation-inhibiting properties

Info

Publication number
ZA959762B
ZA959762B ZA959762A ZA959762A ZA959762B ZA 959762 B ZA959762 B ZA 959762B ZA 959762 A ZA959762 A ZA 959762A ZA 959762 A ZA959762 A ZA 959762A ZA 959762 B ZA959762 B ZA 959762B
Authority
ZA
South Africa
Prior art keywords
fibrinolyic
coagulation
proteins
inhibiting properties
inhibiting
Prior art date
Application number
ZA959762A
Other languages
English (en)
Inventor
Stephan Wnendt
Gerd Josef Steffens
Regina Heinzel-Wieland
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA959762B publication Critical patent/ZA959762B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/101—Plasmid DNA for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA959762A 1994-11-17 1995-11-16 Proteins having fibrinolyic and coagulation-inhibiting properties ZA959762B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4440892A DE4440892A1 (de) 1994-11-17 1994-11-17 Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften

Publications (1)

Publication Number Publication Date
ZA959762B true ZA959762B (en) 1996-09-30

Family

ID=6533447

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959762A ZA959762B (en) 1994-11-17 1995-11-16 Proteins having fibrinolyic and coagulation-inhibiting properties

Country Status (10)

Country Link
US (1) US5976841A (fr)
EP (1) EP0712934A3 (fr)
JP (1) JPH08231594A (fr)
KR (1) KR960017687A (fr)
CA (1) CA2162986A1 (fr)
DE (1) DE4440892A1 (fr)
FI (1) FI955537A (fr)
IL (1) IL115999A0 (fr)
MX (1) MX9504686A (fr)
ZA (1) ZA959762B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892014A (en) * 1996-10-30 1999-04-06 The Regents Of The University Of California DNA encoding a protease-activated receptor 3
US5922540A (en) * 1996-12-20 1999-07-13 Eli Lilly And Company Monofunctional glycosyltransferase gene of Staphylococcus aureus
PL352060A1 (en) * 1999-06-12 2003-07-28 Merck Patent Gmbh Hialuronidase of hiarudinaria manillensis and method of separating, purifying and obtaining thereof by recombination
DE10033195A1 (de) * 2000-07-07 2002-03-21 Aventis Pharma Gmbh Bifunktionale Fusionsproteine aus Hirudin und TAP
EP1737889B1 (fr) 2004-10-19 2010-09-08 Lonza AG Procede de synthese de peptides en phase solide

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187098A (en) * 1984-03-02 1993-02-16 Board Of Regents Of The University Of Oklahoma DNA encoding hybrid streptokinases with plasminogen fibrin binding domains
US5242919A (en) * 1984-08-31 1993-09-07 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1H-indene derivatives
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5204255A (en) * 1986-01-31 1993-04-20 Sagami Chemical Research Center Hybrid tissue plasminogen activator/urokinase polypeptides
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
US5194589A (en) * 1986-09-18 1993-03-16 Pennsylvania Hospital Leech protein having anticoagulant and antimetastatic properties
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
DE3886517T2 (de) * 1987-08-19 1994-04-21 Sagami Chem Res Menschlicher Prourokinase ähnliches Polypeptid.
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8809093D0 (en) * 1988-04-18 1988-05-18 Erba Carlo Spa Low molecular weight derivatives of prourokinase
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
WO1991001142A1 (fr) * 1989-07-20 1991-02-07 Biogen, Inc. Combinaisons et procedes de traitement ou de prevention de maladies thrombotiques
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5189019A (en) * 1990-04-23 1993-02-23 Merck & Co., Inc. Antistasin derived anticoagulant protein
US5328898A (en) * 1990-06-22 1994-07-12 Duke University Factor XIIIA fibrin binding fragments
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5183672A (en) * 1991-04-16 1993-02-02 Gary W. Fetterhoff Apparatus for forming at least one fold line pattern in a rigid plastic material
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5801017A (en) * 1993-04-09 1998-09-01 Bio-Technology General Corp. Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis
US5571708A (en) * 1993-04-19 1996-11-05 Bristol-Myers Squibb Company Thrombin-activatable plasminogen activator
DE4323754C1 (de) * 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften

Also Published As

Publication number Publication date
CA2162986A1 (fr) 1996-05-18
JPH08231594A (ja) 1996-09-10
FI955537A (fi) 1996-05-18
KR960017687A (ko) 1996-06-17
EP0712934A2 (fr) 1996-05-22
EP0712934A3 (fr) 2000-08-23
IL115999A0 (en) 1996-01-31
MX9504686A (es) 1997-04-30
US5976841A (en) 1999-11-02
DE4440892A1 (de) 1996-05-23
FI955537A0 (fi) 1995-11-16

Similar Documents

Publication Publication Date Title
PT2233498E (pt) Proteínas de inibição de calicreína de domínio kunitz e ácidos nucleicos que as codificam
EP1021185A4 (fr) Dihydropyrimidines et leurs emplois
PL308421A1 (en) Viscosimeter
GB9608130D0 (en) Adam proteins and uses thereof
ZA9710338B (en) Proteins
GB9614033D0 (en) Modified protein G and fragments thereof
GB9314802D0 (en) Modified proteins
GB9423372D0 (en) Proteins and their uses
ZA959762B (en) Proteins having fibrinolyic and coagulation-inhibiting properties
IL115317A0 (en) Proteins
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
ZA9510154B (en) Chimeric proteins having fibrinolytic and thrombin-inhibing properties
EP0766693A4 (fr) Nouveaux genes et proteines de proteases de parasites
GB9413316D0 (en) Novel proteins
ZA959512B (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhy-droxyureas
EP0714981A3 (fr) Protéines PRLTS et ADNs codant pour celles-ci
ZA971900B (en) Modified proteins
GB9418147D0 (en) Modified proteins
ZA957852B (en) Proteins
GB9424025D0 (en) Proteins
GB9411089D0 (en) Proteins
GB9420989D0 (en) Protein
LTIP2063A (en) Dessert-cheese and manufacture thereof
GB9624028D0 (en) Modified proteins
GB9614293D0 (en) Modified proteins